GNAI2 and colon adenocarcinoma: These results are consistent with previous functional studies of GNAI1 and GNAI2 in other cancers [20, 63], but our study is the first to experimentally validate the functional roles of these genes in COAD, supporting their candidacy as therapeutic targets.